AtriCurevsThermo Fisher Scientific

ATRC and TMO stock compared: price, dividend, valuation and results, from SEC filings.

ATRC

AtriCure, Inc.

$55.31

Value $2.8B

+1.54%
ATRC's page

TMO

Thermo Fisher Scientific Inc

$691.33

Value $257B

+0.11%
TMO's page

AtriCure (ATRC) has a market value of $2.8B and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, ATRC moved +71.9% and TMO +19.5%. The P/E is 185.1 for ATRC and 36.3 for TMO. Dividend yield: ATRC none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ATRC$2.8B

    TMO$257B

    TMO is 93 times ATRC

  • Revenue, 12 months

    ATRC$590M

    TMO$47.4B

    TMO is 80 times ATRC

  • Net income, 12 months

    ATRC$15M

    TMO$7.1B

    TMO is 475 times ATRC

  • Operating margin

    ATRC2.9%

    TMO17.9%

    15.0 points apart

  • ROIC

    ATRC2.8%

    TMO8.2%

    5.4 points apart

  • P/E

    ATRC185.1

    TMO36.3

    ATRC is 5.1 times TMO

  • Dividend yield

    ATRC0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    ATRC-26.4%

    TMO+11.8%

    38.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ATRC-26.4%

TMO+11.8%

25507510020222023202420252026
Returns by period
PeriodATRCWith dividendsTMOWith dividends
1 year since November 12, 2025+71.9%Price +71.9%+19.5%Price +19.1%
3 years since November 13, 2023+54.1%+15.5% a yearPrice +54.1%+58.8%+16.7% a yearPrice +57.3%
5 years since November 12, 2021-26.4%-5.9% a yearPrice -26.4%+11.8%+2.3% a yearPrice +10.2%
10 years since November 16, 2016+189.3%+11.2% a yearPrice +189.3%+381.8%+17.0% a yearPrice +368.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ATRCAtriCureTMOThermo Fisher Scientific

Valuation

ATRCTMO
Valuation
Price$55.31$691.33
Market value$2.8B$257B
Enterprise value (EV)$2.7B$292B
P/E185.136.3
P/E, 5-year median–32.7
P/B5.24.7
EV/EBIT156.134.5
Free cash flow yield1.9%3.0%

Results and growth

ATRCTMO
Results and growth
Revenue, 12 months$590M$47.4B
Net income, 12 months$15M$7.1B
Free cash flow, 12 months$53M$7.6B
Earnings per share, 12 months$0.30$18.96
Revenue growth, year on year14.9%3.9%
Revenue growth a year, past+21.0%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

ATRCTMO
Margins and returns on capital
Gross margin76.7%–
Operating margin2.9%17.9%
Net margin2.5%14.9%
ROIC2.8%8.2%
ROE3.0%13.4%

Balance sheet

ATRCTMO
Balance sheet
Cash$187M$6.1B
Total debt$97M$41.4B
Net debt / EBITDA-3.33.7
Interest cover3.0×5.5×

Dividends and buybacks

ATRCTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ATRC or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, AtriCure or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 93.2 times AtriCure ($2.8B), at today's prices.

How did ATRC and TMO stock do over the last 10 years?

Since November 16, 2016, ATRC's price moved +189.3% and TMO's +368.4%. With dividends: ATRC +189.3% (+11.2% a year), TMO +381.8% (+17.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, ATRC or TMO?

The dividend yield at today's price is none for AtriCure and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of ATRC and TMO?

At today's price, the P/E is 185.1 for ATRC and 36.3 for TMO. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, AtriCure or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 2.5% for AtriCure and 14.9% for Thermo Fisher Scientific, and the operating margin 2.9% and 17.9%. Revenue was $590M and $47.4B.

Which is the better investment, AtriCure or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.